Dr. Reddy's Laboratories (RDY) Stock Chart & Stock Price History $13.36 +0.14 (+1.02%) Closing price 03/18/2025 03:59 PM EasternExtended Trading$13.32 -0.04 (-0.27%) As of 03/18/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Dr. Reddy's Laboratories Stock Price Performance 5 Day Performance+5.21%1 Month Performance0.00%3 Month Performance-11.67%6 Month Performance-14.77%Year-To-Date Performance-15.42%1 Year Performance-8.64% Receive RDY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Stock Chart for Wednesday, March, 19, 2025 RDY Chart by TradingViewRemove Ads Dr. Reddy's Laboratories Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/18/2025$13.23$13.36+0.98%$13.39$13.301.10 million shs$11.15 billion03/17/2025$12.69$13.23+4.18%$13.26$13.171.80 million shs$11.04 billion03/14/2025$12.64$12.69+0.47%$12.72$12.621.05 million shs$10.60 billion03/13/2025$12.55$12.64+0.72%$12.71$12.511.96 million shs$10.55 billion03/12/2025$12.71$12.55-1.26%$12.67$12.501.51 million shs$10.47 billion03/11/2025$12.70$12.71+0.08%$12.80$12.651.41 million shs$10.61 billion03/10/2025$12.93$12.70-1.83%$12.82$12.67934,186 shs$10.60 billion03/07/2025$12.98$12.93-0.34%$13.03$12.841.52 million shs$10.79 billion03/06/2025$12.92$12.98+0.46%$13.10$12.931.06 million shs$10.83 billion03/05/2025$12.80$12.92+0.94%$13.04$12.801.78 million shs$10.78 billion Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 03/04/2025$12.75$12.80+0.35%$12.87$12.68936,853 shs$10.68 billion03/03/2025$12.77$12.75-0.12%$12.92$12.72958,464 shs$10.64 billion02/28/2025$12.93$12.77-1.24%$12.89$12.622.51 million shs$10.66 billion02/27/2025$13.03$12.93-0.81%$13.04$12.901.90 million shs$10.79 billion02/26/2025$13.12$13.03-0.65%$13.20$13.021.16 million shs$10.88 billion02/25/2025$13.48$13.12-2.67%$13.18$13.022.15 million shs$10.95 billion02/24/2025$13.34$13.48+1.05%$13.50$13.361.53 million shs$11.25 billion02/21/2025$13.44$13.34-0.74%$13.36$13.181.58 million shs$11.13 billion02/20/2025$13.36$13.44+0.60%$13.46$13.341.76 million shs$11.21 billion02/19/2025$13.57$13.36-1.55%$13.39$13.163.04 million shs$11.15 billion02/18/2025$13.60$13.57-0.22%$13.65$13.483.48 million shs$11.32 billion Related Companies argenx Stock Price Chart BioNTech Stock Price Chart Beigene Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart Genmab A/S Stock Price Chart Intra-Cellular Therapies Stock Price Chart Moderna Stock Price Chart Summit Therapeutics Stock Price Chart Viatris Stock Price Chart Sarepta Therapeutics Stock Price Chart Receive RDY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:RDY) was last updated on 3/19/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.